Literature DB >> 1383258

Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.

S Sabbaj1, M F Para, R J Fass, P W Adams, C G Orosz, C C Whitacre.   

Abstract

The lymphocyte proliferative response to recall antigens is lost following HIV infection. We sought to devise a means by which the functional immune status of persons in the early stages of HIV infection could be monitored quantitatively. The response to tetanus toxoid was examined in 45 HIV-infected individuals and 11 controls using conventional lymphocyte proliferative assays concurrently with limiting dilution analysis utilizing the secretion of interleukin-2 as the measure of a response. Our data show that the limiting dilution analysis detects tetanus toxoid-reactive T cells in 80% of those tested, as compared to only 44% by proliferation. However, the frequency of tetanus-reactive T cells in HIV-infected individuals (median frequency = 1/59,156) is decreased five-fold as compared to seronegative controls (median frequency = 1/11,599). Longitudinal studies demonstrated a time-dependent decrease in the frequency of tetanus-specific T cell responses in the HIV-infected individuals. Thus, the limiting dilution analysis is a quantitative approach for detecting antigen-specific T cells in HIV-infected individuals, and may be used to monitor changes in T cell function in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383258     DOI: 10.1007/bf00918092

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.

Authors:  M R Shalaby; J F Krowka; T J Gregory; S E Hirabayashi; S M McCabe; D S Kaufman; D P Stites; A J Ammann
Journal:  Cell Immunol       Date:  1987-11       Impact factor: 4.868

3.  Physiologic activation of T cells via the T cell receptor induces NF-kappa B.

Authors:  C Jamieson; P G McCaffrey; A Rao; R Sen
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

4.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

5.  T cell recognition of HIV synthetic peptides in a natural infection.

Authors:  R D Schrier; J W Gnann; R Landes; C Lockshin; D Richman; A McCutchan; C Kennedy; M B Oldstone; J A Nelson
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

Review 6.  HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises.

Authors:  W C Greene; E Böhnlein; D W Ballard
Journal:  Immunol Today       Date:  1989-08

7.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

Authors:  A Hoffenbach; P Langlade-Demoyen; G Dadaglio; E Vilmer; F Michel; C Mayaud; B Autran; F Plata
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 8.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

Review 9.  Immunopathogenesis of HIV infection.

Authors:  Z F Rosenberg; A S Fauci
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

10.  Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D C Bernstein; D L Mann; G M Shearer; J A Berzofsky
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

View more
  3 in total

1.  T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.

Authors:  A Giovannetti; M Pierdominici; F Mazzetta; S Salemi; M Marziali; D Kuonen; F Iebba; E A Lusi; A Cossarizza; F Aiuti
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Identification of protein kinases dysregulated in CD4(+) T cells in pathogenic versus apathogenic simian immunodeficiency virus infection.

Authors:  P Bostik; P Wu; G L Dodd; F Villinger; A E Mayne; V Bostik; B D Grimm; D Robinson; H J Kung; A A Ansari
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Authors:  Pavel Bostik; Geraldine L Dodd; Francois Villinger; Ann E Mayne; Aftab A Ansari
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.